| Net loss | |
| Depreciation and amortization | 17.29M |
| Loss from impairment charges | |
| Amortization of deferred financing costs | 142K |
| Share-based compensation expense | 2.72M |
| Deferred income taxes | |
| Accounts receivable | -28.87M |
| Income taxes receivable | 0 |
| Inventories, net | -36.04M |
| Prepaid expenses | 652K |
| Accounts payable | 27.36M |
| Accrued expenses | 1.33M |
| Income taxes payable | -90K |
| Deferred rent | -3.14M |
| Other assets and liabilities | 34.2M |
| Net cash used in operating activities | |
| Capital expenditures | -13.33M |
| Net cash used in investing activities | |
| Repayment of debt | -750K |
| Proceeds from exercise of stock options | 120K |
| Net cash used in financing activities | |
| Net decrease in cash and cash equivalents | |
| Cash and cash equivalents at beginning of period | 61.43M |
| Cash and cash equivalents at end of period | 54.01M |